A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback